Orlando Matthew, an insider at Kenvue Inc (KVUE), sold 33,453 shares of company stock on December 14, 2025, at a price of $17.28 per share, totaling $578,000. Following this transaction, Matthew retains 33,453 shares of Kenvue.
Kenvue, a consumer health company based in Summit, New Jersey, manufactures and sells healthcare products, including well-known brands like Tylenol, Neutrogena, and Listerine. The company went public on May 4, 2023, and currently holds a market capitalization of $33.1 billion. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The upcoming earnings report is scheduled for February 4, 2026, with an estimated EPS of $0.23 and revenue of $3.8 billion.
Insider transactions provide transparency into executive actions but should not dictate investment decisions. Various factors can drive insider selling, including personal financial needs and tax planning. Investors are encouraged to look at broader patterns of insider activity rather than isolated transactions when assessing these signals.